Valsartan Mass Tort Lawsuits
Valsartan Attorneys for New Hampshire, Maine, Vermont and Massachusetts
In 2018, the U.S. Food and Drug Administration (FDA) announced a voluntary
recall of certain drugs that contained valsartan after discovering valsartan
had been contaminated by a possible carcinogen. If you or a loved one
took a Valsartan medication and were diagnosed with cancer, you may be
entitled to compensation.
Contact us to discuss your case with our dedicated team.
Valsartan is an angiotensin II receptor blocker that is used to treat high
blood pressure and heart failure. It works by loosening blood vessels
to allow blood to flow more easily through the system. The recent recall
was initiated when an “impurity” that poses potential cancer
risk was detected in valsartan. That impurity, N-nitrosodimethylamine
or NDMA, is classified as a probable human carcinogen. The medicines included
in the voluntary recall are valsartan from Major Pharmaceuticals, Solco
Healthcare, and Teva Pharmaceutical Industries, as well as valsartan/hydrochlorothiazide
from Solco and Teva. The FDA announced in a news release that “the
presence of NDMA was unexpected” and believed to be related to changes
in the manufacturing of valsartan.
NDMA is a Known Carcinogen
NDMA, the impurity recently detected in valsartan, is a known carcinogen
and has been linked to various diseases, including:
- Liver cancer
- Colorectal cancer
- Kidney cancer
- Gastric cancer
- Stomach cancer
Not all valsartan products were recalled, and the FDA is continuing to
review various medications to identify any others contaminated with NDMA.
The agency maintains a
list of the recalled manufacturers and products.
Contact Shaheen & Gordon
At Shaheen & Gordon, P.A. we are committed to helping victims who have
been injured by harmful medications seek the justice and compensation
Contact us now if you or a loved one has been diagnosed with cancer after taking Valsartan